Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer
Status:
Recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
This is a prospective, single-center, open, historically controlled real-world study.
The aims of this study is to evaluate the safety and effectiveness of Nab-paclitaxel combined
with oxaliplatin and S-1 in the treatment of patients with advanced gastric cancer.